Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+7.34%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
9.5%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$125M |
| 2 |
Apple
AAPL
|
$107M |
| 3 |
Microsoft
MSFT
|
$100M |
| 4 |
FedEx
FDX
|
$95.2M |
| 5 |
Fidelity National Information Services
FIS
|
$90M |
Top Sells
| 1 |
Booking.com
BKNG
|
$100M |
| 2 |
Cigna
CI
|
$97.2M |
| 3 |
Phillips 66
PSX
|
$84.3M |
| 4 |
Gilead Sciences
GILD
|
$80.1M |
| 5 |
Snowflake
SNOW
|
$51.2M |
Sector Composition
| 1 | Technology | 26.39% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Airbnb
ABNB
$75.8B
| $398K | ﹤0.01% |
+4,655
| New | +$398K |
|
|
KAMN
827
DELISTED
Kaman Corp
KAMN
| $395K | ﹤0.01% |
+17,723
| New | +$395K |
|
828
US Foods
USFD
$17.5B
| $395K | ﹤0.01% |
+11,606
| New | +$395K |
|
829
National Vision
EYE
$1.86B
| $390K | ﹤0.01% |
10,055
-161
| -2% | -$6.24K |
|
830
CNA Financial
CNA
$13B
| $382K | ﹤0.01% |
9,033
-20,064
| -69% | -$848K |
|
831
Harvard Bioscience
HBIO
$21.3M
| $381K | ﹤0.01% |
137,694
-125,312
| -48% | -$347K |
|
|
DBD
832
DELISTED
Diebold Nixdorf Incorporated
DBD
| $376K | ﹤0.01% |
264,672
-375,927
| -59% | -$534K |
|
833
Equitable Holdings
EQH
$16B
| $376K | ﹤0.01% |
13,089
-202,849
| -94% | -$5.82M |
|
834
MacroGenics
MGNX
$126M
| $374K | ﹤0.01% |
+55,736
| New | +$374K |
|
|
FLIC
835
DELISTED
First of Long Island Corp
FLIC
| $372K | ﹤0.01% |
20,645
-1,013
| -5% | -$18.2K |
|
836
Sangamo Therapeutics
SGMO
$165M
| $369K | ﹤0.01% |
117,524
-12,265
| -9% | -$38.5K |
|
837
CNB Financial Corp
CCNE
$768M
| $368K | ﹤0.01% |
15,464
-925
| -6% | -$22K |
|
838
ODP
ODP
$668M
| $356K | ﹤0.01% |
7,814
-398
| -5% | -$18.1K |
|
839
Best Buy
BBY
$16.1B
| $353K | ﹤0.01% |
+4,406
| New | +$353K |
|
840
Palladyne AI
PDYN
$286M
| $347K | ﹤0.01% |
+103,095
| New | +$347K |
|
841
Univest Financial
UVSP
$898M
| $345K | ﹤0.01% |
13,222
+3,957
| +43% | +$103K |
|
842
LivePerson
LPSN
$89.9M
| $345K | ﹤0.01% |
34,036
-485,507
| -93% | -$4.92M |
|
843
Northfield Bancorp
NFBK
$498M
| $341K | ﹤0.01% |
21,690
-2,849
| -12% | -$44.8K |
|
|
PVLA
844
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $337K | ﹤0.01% |
4,048
-863
| -18% | -$71.8K |
|
845
GlobalFoundries
GFS
$18.5B
| $337K | ﹤0.01% |
6,246
-168
| -3% | -$9.05K |
|
846
Bankwell Financial Group
BWFG
$339M
| $333K | ﹤0.01% |
11,320
-8,210
| -42% | -$242K |
|
847
Origin Bancorp
OBK
$1.21B
| $330K | ﹤0.01% |
9,000
+74
| +0.8% | +$2.72K |
|
848
First Northwest Bancorp
FNWB
$63.2M
| $329K | ﹤0.01% |
21,434
-4,478
| -17% | -$68.8K |
|
849
Axogen
AXGN
$735M
| $328K | ﹤0.01% |
32,869
-1,778
| -5% | -$17.7K |
|
850
EyePoint Pharmaceuticals
EYPT
$966M
| $327K | ﹤0.01% |
+93,432
| New | +$327K |
|